The Online Investor
Accelrys Inc (ACCL)

Accelrys develops and commercializes scientific informatics software and applications that enable customers to accelerate the discovery and development of new products and materials. Co.'s customers include pharmaceutical, biotechnology and other life science companies, and companies in the energy, chemicals, aerospace and packaged goods markets. Co.'s enterprise platform forms the basis of its software and services offerings, which allow users to integrate and deploy scientific solutions spanning data management and informatics, enterprise lab management, modeling and simulation, and workflow automation, as well as performs statistical analysis on data and provides reports to scientists.
Company Name: 
Accelrys Inc
Application Software
Quotes delayed 20 minutes

Email EnvelopeFree ACCL Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Accelrys Inc (ACCL) Page | The Online Investor Page |

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.